FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2024340610> ?p ?o ?g. }

• W2024340610 endingPage "96" @default.
• W2024340610 startingPage "89" @default.
• W2024340610 abstract "The aim of this study was to compare tumor changes in patients with hepatocellular carcinoma receiving sorafenib using evaluation criteria of the American Association for the Study of Liver Diseases (AASLD) and the European Association for the Study of the Liver (EASL) as opposed to the Response Evaluation Criteria in Solid Tumors (RECIST) version 1.1.Twenty-five patients with inoperable hepatocellular carcinoma receiving oral sorafenib underwent magnetic resonance imaging at baseline and follow-up every 8 weeks (range, 2-19 weeks; mean, 7.6 weeks). Data were evaluated retrospectively. Survey time until progression ranged from 5 to 102 weeks (mean, 25.6 weeks), with a total of 54 target lesions being monitored. Additionally, evaluation of serum α-fetoprotein was performed at follow-up.The best response at follow-up using RECIST resulted in rates of 4% objective response (complete remission or partial remission), 24% (progressive disease), and 72% (stable disease). In contrast, AASLD and EASL criteria identified objective responses in 28% and 48%. Twenty percent of all patients classified as having progressive disease by RECIST were identified as having pseudo-progression due to extensive necrosis. Eleven percent of patients classified as having stable disease by RECIST were disclosed as essentially progressive. AASLD area and AASLD diameter disclosed 36% and 40% of patients as having partial remission, respectively, whereas EASL criteria discovered only 24%. There was no significant correlation between serum α-fetoprotein progression and AASLD, EASL, or RECIST evaluation criteria.Response monitoring via functional criteria such as AASLD or EASL criteria is likely to more accurately reflect vital tumor burden in hepatocellular carcinoma compared to RECIST." @default.
• W2024340610 created "2016-06-24" @default.
• W2024340610 creator A5001814278 @default.
• W2024340610 creator A5011943968 @default.
• W2024340610 creator A5012351880 @default.
• W2024340610 creator A5038740193 @default.
• W2024340610 creator A5060962164 @default.
• W2024340610 creator A5062414508 @default.
• W2024340610 creator A5070292978 @default.
• W2024340610 date "2011-01-01" @default.
• W2024340610 modified "2023-09-27" @default.
• W2024340610 title "Comparison of Different Tumor Response Criteria in Patients with Hepatocellular Carcinoma After Systemic Therapy with the Multikinase Inhibitor Sorafenib" @default.
• W2024340610 cites W1971837077 @default.
• W2024340610 cites W2002279402 @default.
• W2024340610 cites W2007557005 @default.
• W2024340610 cites W2012240877 @default.
• W2024340610 cites W2016381292 @default.
• W2024340610 cites W2019607817 @default.
• W2024340610 cites W2020215421 @default.
• W2024340610 cites W2024029636 @default.
• W2024340610 cites W2046507292 @default.
• W2024340610 cites W2054082787 @default.
• W2024340610 cites W2055725726 @default.
• W2024340610 cites W2076163094 @default.
• W2024340610 cites W2076668534 @default.
• W2024340610 cites W2095524430 @default.
• W2024340610 cites W2100576484 @default.
• W2024340610 cites W2107464631 @default.
• W2024340610 cites W2119659417 @default.
• W2024340610 cites W2123172027 @default.
• W2024340610 cites W2123534406 @default.
• W2024340610 cites W2137052325 @default.
• W2024340610 cites W2137488285 @default.
• W2024340610 cites W2138297714 @default.
• W2024340610 cites W2140765540 @default.
• W2024340610 cites W2153867442 @default.
• W2024340610 cites W2153935627 @default.
• W2024340610 cites W2155152791 @default.
• W2024340610 cites W2157769714 @default.
• W2024340610 cites W2163486683 @default.
• W2024340610 cites W2170825454 @default.
• W2024340610 doi "https://doi.org/10.1016/j.acra.2010.08.008" @default.
• W2024340610 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20926315" @default.
• W2024340610 hasPublicationYear "2011" @default.
• W2024340610 type Work @default.
• W2024340610 sameAs 2024340610 @default.
• W2024340610 citedByCount "25" @default.
• W2024340610 countsByYear W20243406102012 @default.
• W2024340610 countsByYear W20243406102013 @default.
• W2024340610 countsByYear W20243406102014 @default.
• W2024340610 countsByYear W20243406102015 @default.
• W2024340610 countsByYear W20243406102016 @default.
• W2024340610 countsByYear W20243406102017 @default.
• W2024340610 countsByYear W20243406102019 @default.
• W2024340610 countsByYear W20243406102020 @default.
• W2024340610 countsByYear W20243406102021 @default.
• W2024340610 countsByYear W20243406102022 @default.
• W2024340610 countsByYear W20243406102023 @default.
• W2024340610 crossrefType "journal-article" @default.
• W2024340610 hasAuthorship W2024340610A5001814278 @default.
• W2024340610 hasAuthorship W2024340610A5011943968 @default.
• W2024340610 hasAuthorship W2024340610A5012351880 @default.
• W2024340610 hasAuthorship W2024340610A5038740193 @default.
• W2024340610 hasAuthorship W2024340610A5060962164 @default.
• W2024340610 hasAuthorship W2024340610A5062414508 @default.
• W2024340610 hasAuthorship W2024340610A5070292978 @default.
• W2024340610 hasConcept C126322002 @default.
• W2024340610 hasConcept C126838900 @default.
• W2024340610 hasConcept C143409427 @default.
• W2024340610 hasConcept C2778019345 @default.
• W2024340610 hasConcept C2778695046 @default.
• W2024340610 hasConcept C2778822529 @default.
• W2024340610 hasConcept C2779134260 @default.
• W2024340610 hasConcept C2779984678 @default.
• W2024340610 hasConcept C2989005 @default.
• W2024340610 hasConcept C71924100 @default.
• W2024340610 hasConceptScore W2024340610C126322002 @default.
• W2024340610 hasConceptScore W2024340610C126838900 @default.
• W2024340610 hasConceptScore W2024340610C143409427 @default.
• W2024340610 hasConceptScore W2024340610C2778019345 @default.
• W2024340610 hasConceptScore W2024340610C2778695046 @default.
• W2024340610 hasConceptScore W2024340610C2778822529 @default.
• W2024340610 hasConceptScore W2024340610C2779134260 @default.
• W2024340610 hasConceptScore W2024340610C2779984678 @default.
• W2024340610 hasConceptScore W2024340610C2989005 @default.
• W2024340610 hasConceptScore W2024340610C71924100 @default.
• W2024340610 hasIssue "1" @default.
• W2024340610 hasLocation W20243406101 @default.
• W2024340610 hasLocation W20243406102 @default.
• W2024340610 hasOpenAccess W2024340610 @default.
• W2024340610 hasPrimaryLocation W20243406101 @default.
• W2024340610 hasRelatedWork W1929717680 @default.
• W2024340610 hasRelatedWork W2338429711 @default.
• W2024340610 hasRelatedWork W2392900588 @default.
• W2024340610 hasRelatedWork W2755922739 @default.
• W2024340610 hasRelatedWork W2800214005 @default.
• W2024340610 hasRelatedWork W2913583221 @default.
• W2024340610 hasRelatedWork W3031914473 @default.

• next